Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination (Q39849945)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Dendritic cells loaded with HIV-1 p24 proteins adsorbed on surfactant-free anionic PLA nanoparticles induce enhanced cellular immune responses against HIV-1 after vaccination (English)

1 reference

Europe PubMed Central

15 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Philippe Roingeard

4

object named as

Philippe Roingeard

1 reference

Europe PubMed Central

15 September 2017

author name string

Fleur Aline

1

1 reference

Europe PubMed Central

15 September 2017

Denys Brand

2

1 reference

Europe PubMed Central

15 September 2017

Josette Pierre

3

1 reference

Europe PubMed Central

15 September 2017

Munier Séverine

5

1 reference

Europe PubMed Central

15 September 2017

Bernard Verrier

6

1 reference

Europe PubMed Central

15 September 2017

Isabelle Dimier-Poisson

7

1 reference

Europe PubMed Central

15 September 2017

language of work or name

0 references

publication date

29 May 2009

1 reference

Europe PubMed Central

15 September 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

15 September 2017

27

1 reference

Europe PubMed Central

15 September 2017

38

1 reference

Europe PubMed Central

15 September 2017

5284-5291

1 reference

Europe PubMed Central

15 September 2017

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Dendritic cell-based cancer immunotherapy targeting MUC-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Peptide-loaded dendritic-cell vaccination followed by treatment interruption for chronic HIV-1 infection: a phase 1 trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Therapeutic immunization with human immunodeficiency virus type 1 (HIV-1) peptide-loaded dendritic cells is safe and induces immunogenicity in HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Nanoparticles target distinct dendritic cell populations according to their size

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

B cell tumor vaccine enhanced by covalent attachment of immunoglobulin to surface proteins on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.028

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2009.05.028

1 reference

Europe PubMed Central

15 September 2017

1 reference

Europe PubMed Central

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39849945&oldid=2091478392"